Literature DB >> 11793879

A review of techniques for the investigation of otitis externa and otitis media.

K M Murphy1.   

Abstract

Otitis externa, inflammation of the externa ear canal, is relatively easy to diagnose based on the history and physical examination findings. The diagnosis of otitis media, inflammation of the middle ear cavity, is more challenging, with the work-up being both costly and, at times, invasive. The pathogenesis of otitis externa has been classified into predisposing, primary, and perpetuating factors. It is critical to the management of ear disease that the clinician recognize and investigate which factors are contributing to each individual patient's ear disease. Failure to identify and address the primary and/or predisposing factors is the most common cause of chronic recurrent otitis externa. Chronic inflammation of the ear canal leads to the development of the perpetuating factors, which may be the major reason for treatment failure, regardless of the primary cause of the ear disease. In this article, the predisposing, primary, and perpetuating factors involved in ear disease will be presented, along with a review of the techniques used in the diagnosis of otitis externa and otitis media.

Entities:  

Mesh:

Year:  2001        PMID: 11793879     DOI: 10.1053/svms.2001.27601

Source DB:  PubMed          Journal:  Clin Tech Small Anim Pract        ISSN: 1096-2867


  3 in total

1.  Middle ear cholesteatoma in 11 dogs.

Authors:  Valentina Greci; Olga Travetti; Mauro Di Giancamillo; Rocco Lombardo; Chiara Giudice; Barbara Banco; Carlo M Mortellaro
Journal:  Can Vet J       Date:  2011-06       Impact factor: 1.008

2.  Epidemiological study of dogs with otitis externa in Cape Breton, Nova Scotia.

Authors:  Laura R Perry; Bernard MacLennan; Rebecca Korven; Timothy A Rawlings
Journal:  Can Vet J       Date:  2017-02       Impact factor: 1.008

3.  Chronic Otitis Externa Secondary to Tympanic Membrane Electrode Placement in Rhesus Macaques (Macaca mulatta).

Authors:  Jane A Burton; Alejandro L Tarabillo; Kelsey R Finnie; Katherine A Shuster; Chase A Mackey; Troy A Hackett; Ramnarayan Ramachandran
Journal:  Comp Med       Date:  2022-03-28       Impact factor: 1.565

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.